Roche's Coronavirus Rapid Antigen Test Approved in Germany
February 26 2021 - 1:23PM
Dow Jones News
By Mauro Orru
Roche Holding AG said Friday that the German Federal Institute
for Drugs and Medical Devices gave special approval for its
SARS-CoV-2 rapid antigen test for at-home use.
The Swiss pharmaceutical major said the test collects samples
from the front area of the nose instead of the nasopharynx and can
be performed at home with results available in 15 minutes.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
February 26, 2021 13:08 ET (18:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Sep 2023 to Sep 2024
